IDEXX Laboratories Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 77 trades in IDEXX Laboratories Inc (NASDAQ: IDXX) since 2013, across 12 members, worth an estimated $1.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 35 buys against 42 sells, a modestly sell-led skew, with Democratic members responsible for 71% of the trades and Republican members 29%. The most recent disclosure shown was filed April 2026, and Ro Khanna has filed the most IDXX transactions among those shown, with 7. Other recent filers include April Mcclain Delaney and Byron Donalds. One notable disclosed move was a sale by April Mcclain Delaney on January 13, 2026, down 21.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the IDEXX Laboratories Inc (IDXX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
IDEXX Laboratories congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Ro Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | BUY |  $15,001 - $50,000 | +0.65% | |
Ro Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | BUY | $1,001 - $15,000 | -13.63% | |
Ro Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | SELL | $1,001 - $15,000 | -10.45% | |
Ro Khanna House | Feb 6, 2026 | Jan 23, 2026 | 14 days | SELL | $1,001 - $15,000 | -19.19% | |
| Feb 2, 2026 | Jan 13, 2026 | 20 days | SELL | $1,001 - $15,000 | -21.47% | ||
| Nov 4, 2025 | Oct 16, 2025 | 19 days | SELL | $1,001 - $15,000 | -12.02% | ||
Ro Khanna House | Nov 6, 2025 | Oct 7, 2025 | 30 days | BUY | $1,001 - $15,000 | -10.61% | |
Ro Khanna House | Oct 3, 2025 | Sep 5, 2025 | 28 days | SELL | $1,001 - $15,000 | -12.79% | |
 Byron Donalds House | Oct 7, 2025 | Sep 4, 2025 | 33 days | BUY | $1,001 - $15,000 | -12.45% | |
| Sep 2, 2025 | Aug 7, 2025 | 26 days | SELL | $1,001 - $15,000 | -13.74% |
IDEXX Laboratories (IDXX) congressional trading FAQ
Can members of Congress legally trade IDEXX Laboratories (IDXX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including IDEXX Laboratories (IDXX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional IDEXX Laboratories (IDXX) trades public?
Yes. Every congressional trade in IDEXX Laboratories (IDXX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded IDEXX Laboratories (IDXX)?
Members of Congress have disclosed 77 trades in IDEXX Laboratories (IDXX) worth $1.1M across 12 members, according to public STOCK Act filings.
Which members of Congress have traded IDEXX Laboratories (IDXX)?
Recent and active filers of IDEXX Laboratories (IDXX) disclosures include Ro Khanna, April Mcclain Delaney, Byron Donalds. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade IDEXX Laboratories (IDXX) more?
Across disclosed IDEXX Laboratories (IDXX) trades, 71% were by Democrats and 29% by Republicans, led by Democrats (71%).
What is the most recent congressional IDEXX Laboratories (IDXX) trade?
The most recent disclosed IDEXX Laboratories (IDXX) trade was a purchase by Ro Khanna, filed Apr 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewIDEXX Laboratories (IDXX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.